Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
As the COVID-19 is still growing throughout the globe, a thorough investigation into the specific immunopathology of SARS-CoV-2, its interaction with the host immune system and pathogen evasion mechanism may provide a clear picture of how the pathogen can breach the host immune defenses in elderly p...
Main Authors: | Rudra P. Saha, Ashish Ranjan Sharma, Manoj K. Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang-Soo Lee, Chiranjib Chakraborty |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01258/full |
Similar Items
-
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
by: Chiranjib Chakraborty, et al.
Published: (2021-11-01) -
Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential
by: Ashish Ranjan Sharma, et al.
Published: (2021-09-01) -
The 2019 novel coronavirus disease (COVID-19) pandemic: A zoonotic prospective
by: Chiranjib Chakraborty, et al.
Published: (2020-01-01) -
From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
by: Chiranjib Chakraborty, et al.
Published: (2021-07-01) -
L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies
by: Wezi Sendama
Published: (2020-01-01)